中草药

羊肚菌多糖调控肠道菌群干预机体机能研究进展

PDF下载

中草药 | 综述 2026,57(6): 2368-2380

收起

中草药 |综述 2026 , 57 (6) : 2368 -2380

羊肚菌多糖调控肠道菌群干预机体机能研究进展

全屏

赵瑞华^1,2, 姬萌¹, 谢佳艺³, 靳鹏飞^1,2, 贺晓龙^1,2, 陈国梁^1,2

作者信息

作者简介:

赵瑞华: 赵瑞华,副教授,硕士生导师,从事食药用真菌学研究。E-mail:zhaohua506@sohu.com

Research progress on Morchella polysaccharides regulating gut microbiota and intervening in body function

ZHAO Ruihua, JI Meng, XIE Jiayi, JIN Pengfei, HE Xiaolong, CHEN Guoliang

Affiliations

doi: 10.7501/j.issn.0253-2670.2026.06.029

文章导航

摘要

收起

羊肚菌Morchella spp.是一类珍贵的食药用真菌，其多糖因良好的生物安全性与多样的生理活性，成为近年来天然产物领域的研究热点。大量研究揭示羊肚菌多糖（Morchellapolysaccharides，MPs）通过影响肠道菌群的组成和代谢，进而调节宿主机体功能的机制。MPs可选择性促进肠道有益共生菌增殖，同时抑制潜在致病菌，从而缓解与菌群失调相关的疾病。此外，MPs可被肠道菌群降解为具有生物活性的代谢产物，如短链脂肪酸（short-chain fatty acids，SCFAs）。这些代谢产物不仅促进MPs的吸收，还在维持肠道屏障功能、抑制炎症、调节免疫反应等方面发挥重要作用。通过综述MPs的分离、纯化方法，MPs在肠道内的降解过程，MPs对肠道菌群结构及SCFAs生成的影响，及MPs通过靶向肠道菌群对宿主产生的有益作用，揭示MPs-肠道菌群-宿主机体功能间的相互机制，为MPs的临床应用及功能性食品的开发提供理论依据。

关键词

羊肚菌多糖 / 肠道菌群 / 短链脂肪酸 / 机体机能 / 免疫调节 / 肠道屏障

Abstract

收起

Morchella spp. are a group of precious edible and medicinal fungi. Their polysaccharides have become a research hotspot in the field of natural products in recent years due to their excellent biological safety and diverse physiological activities. In recent years, many studies have revealed the mechanism by which Morchella polysaccharides (MPs) can regulate host body function by influencing the composition and metabolism of gut microbiota. MPs can selectively promote the proliferation of beneficial commensal bacteria in the gut while inhibiting potential pathogenic bacteria, thereby alleviating diseases associated with gut microbiota dysbiosis. Moreover, MPs can be degraded by the gut microbiota into biologically active metabolites, such as short-chain fatty acids (SCFAs). These metabolites not only promote the absorption of polysaccharides, but also play essential roles in maintaining the intestinal barrier function, regulating immune responses, and inhibiting inflammation. The current review summarizes the isolation and purification methods of MPs, the degradation of MPs in intestine, the impacts of MPs on gut microbiota community and SCFAs productivity, as well as the beneficial effects of MPs to host by targeting gut microbiota, and reveals the interaction mechanism among MPs, gut microbiota and host body function. We hope this article can offer some theoretical bases and inspirations for the clinical application of MPs and the development of functional foods.

Key words

Morchella polysaccharides / gut microbiota / short-chain fatty acids / body function / immune regulation / intestinal barrier

引用本文

赵瑞华, 姬萌, 谢佳艺, 靳鹏飞, 贺晓龙, 陈国梁. 羊肚菌多糖调控肠道菌群干预机体机能研究进展. 中草药, 2026 , 57 (6) : 2368 -2380 . DOI: 10.7501/j.issn.0253-2670.2026.06.029

ZHAO Ruihua, JI Meng, XIE Jiayi, JIN Pengfei, HE Xiaolong, CHEN Guoliang. Research progress on Morchella polysaccharides regulating gut microbiota and intervening in body function[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (6) : 2368 -2380 . DOI: 10.7501/j.issn.0253-2670.2026.06.029

基金

收起

国家自然科学基金资助项目 (32260797); 2025年度陕能院校级科研项目 (2025KYZRZ02)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

Pushpanathan P, Mathew G S, Selvarajan S, et al. Gut microbiota and its mysteries[J]. Indian J Med Microbiol, 2019, 37(2): 268-277.
Shang Z F, Pai L, Patil S. Unveiling the dynamics of gut microbial interactions: A review of dietary impact and precision nutrition in gastrointestinal health[J]. Front Nutr, 2024, 11: 1395664.
Dao M C, Clément K. Gut microbiota and obesity: Concepts relevant to clinical care[J]. Eur J Intern Med, 2018, 48: 18-24.
Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(4): 223-237.
赵瑞华. 组学视角下羊肚菌抗逆响应机制的研究进展[J]. 菌物学报, 2025, 44(6): 1-14.
尚千涵, 杨婷, 高其媛, 等. 羊肚菌属物种分类、系统进化和药用价值研究进展[J]. 中草药, 2021, 52(7): 2154-2162.
尚千涵, 高其媛, 杨婷, 等. 羊肚菌属群体遗传学和基因组进化的研究进展[J]. 中草药, 2021, 52(18): 5782-5788.
Wen Y, Bi S X, Hu X J, et al. Structural characterization and immunomodulatory mechanisms of two novel glucans from Morchella importuna fruiting bodies[J]. Int J Biol Macromol, 2021, 183: 145-157.
Liu B S, Tomtong P, Charoensiddhi S, et al. Exploring Morchella esculenta polysaccharide extracts: In vitro digestion, fermentation characteristics, and prebiotic potential for modulating gut microbiota and function[J]. Int J Biol Macromol, 2025, 318(Pt1): 144910.
裴龙英, 杨丽, 王思丹, 等. 低共熔溶剂提取羊肚菌多糖工艺优化及其益生菌增殖作用[J]. 食品工业科技, 2025, 46(15): 255-265.
Ma G X, Du H J, Hu Q H, et al. Health benefits of edible mushroom polysaccharides and associated gut microbiota regulation[J]. Crit Rev Food Sci Nutr, 2022, 62(24): 6646-6663.
Zhang J X, Zhao J Y, Liu G Y, et al. Advance in Morchella sp. polysaccharides: Isolation, structural characterization and structure-activity relationship: A review[J]. Int J Biol Macromol, 2023, 247: 125819.
Huo W Y, Feng Z P, Hu S Y, et al. Effects of polysaccharides from wild morels on immune response and gut microbiota composition in non-treated and cyclophosphamide-treated mice[J]. Food Funct, 2020, 11(5): 4291-4303.
Huo W Y, Qi P, Cui L J, et al. Polysaccharide from wild morels alters the spatial structure of gut microbiota and the production of short-chain fatty acids in mice[J]. Biosci Microbiota Food Health, 2020, 39(4): 219-226.
Wang S R, Li D J, Li G L, et al. Functional properties, rheological characteristics, simulated digestion, and fermentation by human fecal microbiota of polysaccharide from Morchella importuna[J]. Foods, 2024, 13(13): 2148.
宋光明. 超细羊肚菌粉多糖的提取、体外消化酵解及泡腾片制作[D]. 重庆: 西南大学, 2023.
Rehman A U, Khan A I, Xin Y, et al. Morchella esculenta polysaccharide attenuate obesity, inflammation and modulate gut microbiota[J]. AMB Express, 2022, 12(1): 114.
Zang X J, Jin X, Liu B S, et al. Morchella esculenta polysaccharides ameliorate obesity by enriching Bifidobacterium and Bacteroides[J]. Food Biosci, 2025, 68: 106552.
Zhang Z Y, Cui Y M, Zhang X S, et al. Gut microbiota combined with serum metabolites to reveal the effect of Morchella esculenta polysaccharides on lipid metabolism disordered in high-fat diet mice[J]. Int J Biol Macromol, 2024, 281(Pt 2): 136380.
Rehman A U, Siddiqui N Z, Farooqui N A, et al. Morchella esculenta mushroom polysaccharide attenuates diabetes and modulates intestinal permeability and gut microbiota in a type 2 diabetic mice model[J]. Front Nutr, 2022, 9: 984695.
Wu H S, Chen J, Liu Y T, et al. Digestion profile, antioxidant, and antidiabetic capacity of Morchella esculenta exopolysaccharide: In vitro, in vivo and microbiota analysis[J]. J Sci Food Agric, 2023, 103(9): 4401-4412.
Pan X, Meng J L, Xu L J, et al. In-depth investigation of the hypoglycemic mechanism of Morchella importuna polysaccharide via metabonomics combined with 16S rRNA sequencing[J]. Int J Biol Macromol, 2022, 220: 659-670.
Liu B S, Yu L L, Zhai Q X, et al. Effect of water-soluble polysaccharides from Morchella esculenta on high-fat diet-induced obese mice: Changes in gut microbiota and metabolic functions[J]. Food Funct, 2023, 14(11): 5217-5231.
李东洁. 羊肚菌酶解多糖的制备及其调节脂代谢紊乱的作用机制[D]. 太谷: 山西农业大学, 2024.
Guo W H, Wang X R, Wang B, et al. In vitro digestion and fecal fermentation behaviors of exopolysaccharide from Morchella esculenta and its impacts on hypoglycemic activity via PI3K/Akt signaling and gut microbiota modulation[J]. Food Chem X, 2024, 24: 101870.
Teng S S, Zhang Y F, Jin X H, et al. Structure and hepatoprotective activity of Usp10/NF-κB/Nrf2 pathway-related Morchella esculenta polysaccharide[J]. Carbohydr Polym, 2023, 303: 120453.
赵敏吉. 羊肚菌柄粗多糖对溃疡性结肠炎小鼠的缓解作用及其功能性饮料研究[D]. 重庆: 重庆工商大学, 2023.
王志超. 羊肚菌降解多糖的制备及其对溃疡性结肠炎小鼠的保护作用机制[D]. 太谷: 山西农业大学, 2024.
Zhang Y J, Qiu R, Zhang Z F, et al. Effect of Morchella esculenta polysaccharides on the rectal microbiota of mice challenged with lipopolysaccharides[J]. Front Vet Sci, 2024, 11: 1446924.
Li P, Dai X F, Chen X F, et al. Recent advances in the bioactive polysaccharides and other key components from Morchella spp. and biological activities: A review[J]. Carbohydr Res, 2025, 554: 109515.
Ma X, Tang J, Zhang F, et al. Antioxidant and immunomodulatory effects of acetylated Morchella esculenta polysaccharide in DSS-induced ulcerative colitis mice[J]. Bioorg Chem, 2025, 163: 108669.
Xiong C, Li P, Luo Q, et al. Effect of γ-irradiation on the structure and antioxidant activity of polysaccharide isolated from the fruiting bodies of Morchella sextelata[J]. Biosci Rep, 2020, 40(9): BSR20194522.
Li S H, Tang D, Wei R, et al. Polysaccharides production from soybean curd residue via Morchella esculenta[J]. J Food Biochem, 2019, 43(4): e12791.
Li F, Lei H J, Xu H D. Influences of subcritical water extraction on the characterization and biological properties of polysaccharides from Morchella sextelata[J]. Food Processing Preservation, 2022, 46(9): e16024.
Meng X, Che C C, Zhang J M, et al. Structural characterization and immunomodulating activities of polysaccharides from a newly collected wild Morchella sextelata[J]. Int J Biol Macromol, 2019, 129: 608-614.
Khan I, Huang G X, Li X A, et al. Mushroom polysaccharides from Ganoderma lucidum and Poria cocos reveal prebiotic functions[J]. J Funct Foods, 2018, 41: 191-201.
Sonnenburg E D, Zheng H J, Joglekar P, et al. Specificity of polysaccharide use in intestinal Bacteroides species determines diet-induced microbiota alterations[J]. Cell, 2010, 141(7): 1241-1252.
Colucci Cante R, Nigro F, Passannanti F, et al. Gut health benefits and associated systemic effects provided by functional components from the fermentation of natural matrices[J]. Compr Rev Food Sci Food Saf, 2024, 23(3): e13356.
Tian J J, Wang X M, Zhang X L, et al. Artificial simulated saliva, gastric and intestinal digestion and fermentation in vitro by human gut microbiota of intrapolysaccharide from Paecilomyces cicadae TJJ1213[J]. Food Sci Hum Wellness, 2023, 12(2): 622-633.
El Kaoutari A, Armougom F, Gordon J I, et al. The abundance and variety of carbohydrate-active enzymes in the human gut microbiota[J]. Nat Rev Microbiol, 2013, 11(7): 497-504.
Song Q Q, Wang Y K, Huang L X, et al. Review of the relationships among polysaccharides, gut microbiota, and human health[J]. Food Res Int, 2021, 140: 109858.
Palmnäs-Bédard M S A, Costabile G, Vetrani C, et al. The human gut microbiota and glucose metabolism: A scoping review of key bacteria and the potential role of SCFAs[J]. Am J Clin Nutr, 2022, 116(4): 862-874.
Schönfeld P, Wojtczak L. Short- and medium-chain fatty acids in energy metabolism: The cellular perspective[J]. J Lipid Res, 2016, 57(6): 943-954.
Tan J, McKenzie C, Potamitis M, et al. The role of short-chain fatty acids in health and disease[J]. Adv Immunol, 2014, 121: 91-119.
Yin C M, Noratto G D, Fan X Z, et al. The impact of mushroom polysaccharides on gut microbiota and its beneficial effects to host: A review[J]. Carbohydr Polym, 2020, 250: 116942.
Ríos-Covián D, Ruas-Madiedo P, Margolles A, et al. Intestinal short chain fatty acids and their link with diet and human health[J]. Front Microbiol, 2016, 7: 185.
Morrison D J, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism[J]. Gut Microbes, 2016, 7(3): 189-200.
Singh V, Lee G, Son H, et al. Butyrate producers, “The sentinel of gut”: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics[J]. Front Microbiol, 2023, 13: 1103836.
Trachsel J, Bayles D O, Looft T, et al. Function and phylogeny of bacterial butyryl coenzyme A: Acetate transferases and their diversity in the proximal colon of swine[J]. Appl Environ Microbiol, 2016, 82(22): 6788-6798.
Shi N, Li N, Duan X W, et al. Interaction between the gut microbiome and mucosal immune system[J]. Mil Med Res, 2017, 4: 14.
van der Beek C M, Bloemen J G, van den Broek M A, et al. Hepatic uptake of rectally administered butyrate prevents an increase in systemic butyrate concentrations in humans[J]. J Nutr, 2015, 145(9): 2019-2024.
Kimura I, Ozawa K, Inoue D, et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43[J]. Nat Commun, 2013, 4: 1829.
Yoshida H, Ishii M, Akagawa M. Propionate suppresses hepatic gluconeogenesis via GPR43/AMPK signaling pathway[J]. Arch Biochem Biophys, 2019, 672: 108057.
Fu X, Cao C L, Ren B B, et al. Structural characterization and in vitro fermentation of a novel polysaccharide from Sargassum thunbergii and its impact on gut microbiota[J]. Carbohydr Polym, 2018, 183: 230-239.
Liu B N, Liu X T, Liang Z H, et al. Gut microbiota in obesity[J]. World J Gastroenterol, 2021, 27(25): 3837-3850.
Yu C X, Dong Q, Chen M J, et al. The effect of mushroom dietary fiber on the gut microbiota and related health benefits: A review[J]. J Fungi, 2023, 9(10): 1028.
LeBlanc J G, Milani C, de Giori G S, et al. Bacteria as vitamin suppliers to their host: A gut microbiota perspective[J]. Curr Opin Biotechnol, 2013, 24(2): 160-168.
Cornejo-Pareja I, Muñoz-Garach A, Clemente-Postigo M, et al. Importance of gut microbiota in obesity[J]. Eur J Clin Nutr, 2019, 72(Suppl 1): 26-37.
Di Porzio A, Barrella V, Gatto C, et al. Protective effect of probiotic Limosilactobacillus reuteri DSM17938 against western diet-induced obesity and associated metabolic alterations[J]. J Funct Foods, 2023, 109: 105805.
Di Lorenzo F, De Castro C, Silipo A, et al. Lipopolysaccharide structures of Gram-negative populations in the gut microbiota and effects on host interactions[J]. FEMS Microbiol Rev, 2019, 43(3): 257-272.
Puddu A, Sanguineti R, Montecucco F, et al. Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes[J]. Mediators Inflamm, 2014, 2014: 162021.
Rooks M G, Garrett W S. Gut microbiota, metabolites and host immunity[J]. Nat Rev Immunol, 2016, 16(6): 341-352.
任媛, 贺敏, 曾千, 等. 植物来源囊泡防治炎症性肠病的疗效、机制评价及药用开发前景[J]. 中草药, 2024, 55(23): 8208-8221.
尹园缘, 李慧雯, 何永恒. 基于CiteSpace和VOSviewer的肠道菌群与溃疡性结肠炎相关性研究现状及趋势的可视化分析[J]. 中草药, 2025, 56(19): 7130-7145.
Wang T, Wang P P, Ge W P, et al. Protective effect of a multi-strain probiotics mixture on azoxymethane/dextran sulfate sodium-induced colon carcinogenesis[J]. Food Biosci, 2021, 44: 101346.
谢译萱, 魏雪梅, 杨洋, 等. 基于肠道菌群-胆汁酸轴探讨中药治疗炎症性肠病的研究进展[J]. 中草药, 2025, 56(22): 8403-8413.
Wang M, Fu R J, Xu D Q, et al. Traditional Chinese medicine: A promising strategy to regulate the imbalance of bacterial flora, impaired intestinal barrier and immune function attributed to ulcerative colitis through intestinal microecology[J]. J Ethnopharmacol, 2024, 318(PtA): 116879.
Sun M, He C, Cong Y, et al. Regulatory immune cells in regulation of intestinal inflammatory response to microbiota[J]. Mucosal Immunol, 2015, 8(5): 969-978.
Wang H B, Wang P Y, Wang X, et al. Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription[J]. Dig Dis Sci, 2012, 57(12): 3126-3135.
Liu X M, Mao B Y, Gu J Y, et al. Blautia-a new functional genus with potential probiotic properties?[J]. Gut Microbes, 2021, 13(1): 1875796.
Osman N, Adawi D, Molin G, et al. Bifidobacterium infantis strains with and without a combination of oligofructose and inulin (OFI) attenuate inflammation in DSS-induced colitis in rats[J]. BMC Gastroenterol, 2006, 6: 31.
Zhang N N, Ma H, Zhang Z F, et al. Characterization and immunomodulatory effect of an alkali-extracted galactomannan from Morchella esculenta[J]. Carbohydr Polym, 2022, 278: 118960.
Tang C, Ding R X, Sun J, et al. The impacts of natural polysaccharides on intestinal microbiota and immune responses-a review[J]. Food Funct, 2019, 10(5): 2290-2312.
Kato L M, Kawamoto S, Maruya M, et al. The role of the adaptive immune system in regulation of gut microbiota[J]. Immunol Rev, 2014, 260(1): 67-75.
Shen F, Zhu H T, Bao Z Y, et al. Lactiplantibacillus plantarum T34 alleviates constipation by enhancing intestinal barrier and modulating gut homeostasis[J]. Food Biosci, 2025, 66: 106195.
陈玉琼, 顾天宇, 张思, 等. 短链脂肪酸在炎症性肠病中的免疫调节作用[J]. 现代免疫学, 2021, 41(3): 255-259.
Markowiak-Kopeć P, Śliżewska K. The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome[J]. Nutrients, 2020, 12(4): 1107.
Vinolo M A R, Rodrigues H G, Nachbar R T, et al. Regulation of inflammation by short chain fatty acids[J]. Nutrients, 2011, 3(10): 858-876.
Liu T Z, Sun Z, Yang Z C, et al. Microbiota-derived short-chain fatty acids and modulation of host-derived peptides formation: Focused on host defense peptides[J]. Biomed Pharmacother, 2023, 162: 114586.
Dong Y H, Qi Y R, Liu M, et al. Antioxidant, anti-hyperlipidemia and hepatic protection of enzyme-assisted Morehella esculenta polysaccharide[J]. Int J Biol Macromol, 2018, 120(PtB): 1490-1499.
Meng B, Zhang Y Z, Wang Z Q, et al. Hepatoprotective effects of Morchella esculenta against alcohol-induced acute liver injury in the C57BL/6 mouse related to Nrf-2 and NF-κB signaling[J]. Oxid Med Cell Longev, 2019, 2019: 6029876.
Yang J P, Li Y N, Wen Z Q, et al. Oscillospira-a candidate for the next-generation probiotics[J]. Gut Microbes, 2021, 13(1): 1987783.
Cui Y L, Zhang L S, Wang X, et al. Roles of intestinal Parabacteroides in human health and diseases[J]. FEMS Microbiol Lett, 2022, 369(1): fnac072.
Parker B J, Wearsch P A, Veloo A C M, et al. The genus Alistipes: Gut bacteria with emerging implications to inflammation, cancer, and mental health[J]. Front Immunol, 2020, 11: 906.
Larsen J M. The immune response to Prevotella bacteria in chronic inflammatory disease[J]. Immunology, 2017, 151(4): 363-374.

2026年第57卷第6期

PDF下载

引用本文

BibTeX

文章信息

doi: 10.7501/j.issn.0253-2670.2026.06.029

接收时间：2025-10-17
首发时间：2026-09-09

补充材料

相关文章

文章信息

作者

出版历史

收稿日期：2025-10-17

基金

作者信息

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.06.029

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT